Effect Of Sarpagandha Vati and Haritaki churna in hypertension

Anti hypertensive Efficacy Of Combination Therapy Of Sarpagandha Vati With Anuloman Chikitsa(Haritaki Churna) On Vyana Bala Vaishamya(Hypertension) randomised clinical trial - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067985

Enrollment

Registered

2024-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient of either sex with age between 18-50 years. Newly diagnosed stage1 primary hypertensive patients( not on medication)

Exclusion criteria

Exclusion criteria: Primary hypertension other than stage1 eg. stage2, Benign hypertension, malignant hypertension, isolated hypertension. Secondary hypertension. Stage1, primary hypertension with co morbidities. Stage1 hypertensive patient on regular medication. Pregnant woman and lactating mother. Gestational hypertension.

Design outcomes

Primary

Measure	Time frame
Improvement in symptoms of Vyana Bala Vaishamya(Hypertension). Reduction in blood pressure readings.Timepoint: 12 Months	—

Secondary

Measure	Time frame
The study will provide cost effective safe drug with lesser side effects.Timepoint: 12 Months	—

Countries

India

Contacts

Public ContactDr Ashok Kumar Madan Singh

Ch Brahm Prakash Ayurved Charak Sansthan

ashokdagar01@gmail.com9899867606

Outcome results